Association between obstructive sleep apnea (OSA) and cancer incidence – A nationwide population-based study Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Sleep disordered breathing is very prevalent in patients with lung cancer : Preliminary results of the SAIL study (Sleep Apnea In Lung cancer) Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: Longitudinal data from the European Sleep Apnea Database (ESADA) Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
Vasopressin in patients with obstructive sleep apnoea syndrome – An interventional, case-control study Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Lung function impairment in relation with obstructive sleep apnea and obesity: the Rotterdam Study Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020
Obstructive sleep apnea and cardiovascular risk markers in community individuals- Results from the sleep apnea and vascular evaluation (SAVE) study Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA) study Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP) Year: 2018
Determinants of daytime sleepiness in mild obstructive sleep apnoea syndrome. Data from the European Sleep Apnoea Database (ESADA) cohort study. Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018
Mild obstructive sleep apnoea (OSA) and arterial hypertension in the EuropeanSleep Apnoea Database (ESADA) cohort study. Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea Year: 2018
Prevalence of hyperuricemia in patients with obstructive sleep apnea from the Mallorca cohort Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA) Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021
LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA) Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19 Source: Sleep and Breathing Conference 2021 Year: 2021
The sleepy phenotype in mild Obstructive Sleep Apnoea (OSA) patients: from clinical characteristics to cardiometabolic risk. Data from the European Sleep Apnea Database (ESADA). Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders Year: 2021
Obstructive Sleep Apnea (OSAS) in a clinical cohort of children. Atlantis Study Source: International Congress 2017 – What is new in respiratory and sleep physiology? Year: 2017
Obstructive sleep apnea is an independent predictor for dyslipidemia: Data from the European Sleep Apnea Database (ESADA) Source: International Congress 2017 – Central sleep apnoea: consequences and comorbidities of obstructive sleep apnoea Year: 2017
Prevalence of restless legs syndrome among patients with obstructive sleep apnea before and after CPAP treatment, compared to the general population. The Icelandic Sleep Apnea Cohort (ISAC) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Overnight changes in lung function in patients with obstructive sleep apnoea Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies Year: 2015
Chronic Obstructive Pulmonary Disease (COPD) as co-morbidity in patients with Obstructive Sleep Apnea Syndrome (OSAS): Results of a retrospective study in the French overseas department of Reunion island. Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities Year: 2021